Enosis and OVID To Launch In-Clinic Pilot Offering of Psychedelic-Augmented Psychotherapy Leveraging Virtual Reality Technology MELBOURNE, Australia, Oct. 31, 2022 /PRNewswire/ — Enosis Therapeutics, (or ‘Enosis’), a medical technology and psychedelic research company that leverages virtual reality (VR) for the contextual modulation of psychedelic therapy to improve treatment outcomes…

Source

Previous articleApex Labs Granted Approval for North America’s First Take Home Psilocybin Clinical Trial
Next articleFree Webinar – NueLife: Empowering Patients with At-Home Ketamine Therapy